Clinical Evaluation of the Free Margin Cusp Sizer (CALIBRATE)

Sponsor
Cliniques universitaires Saint-Luc- Université Catholique de Louvain (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT04797572
Collaborator
(none)
80
1
45.6

Study Details

Study Description

Brief Summary

The objective of this study is to investigate safety and performance of the Free Margin Cusp sizer. The device will be used during aortic valve repair and sparing procedures as a caliper to measure the aortic valve free margin length at different stages of the procedure. The patient will be followed for one year clinically (at 1, 2, 6 and 12 months) and by echocardiography (at 6 and 12 months) to assess aortic valve function.

Condition or Disease Intervention/Treatment Phase
  • Device: Free Margin Cusp Sizer
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
80 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
CALIBRATE TRIAL: a Prospective, Single Arm Investigational Clinical Trial Evaluating Safety and Performance of the Free Margin Cusp Sizer During Aortic Valve Repair Surgery
Anticipated Study Start Date :
Mar 15, 2021
Anticipated Primary Completion Date :
Aug 1, 2024
Anticipated Study Completion Date :
Jan 1, 2025

Arms and Interventions

Arm Intervention/Treatment
Other: Treated group

Patients in whom the free margin cusp sizer will be used to measure the free margin of the three leaflets of the aortic valve during aortic valve repair.

Device: Free Margin Cusp Sizer
The free margin cusp sizer will be used during aortic valve repair and sparing procedures as a caliper to measure the aortic valve free margin length.

Outcome Measures

Primary Outcome Measures

  1. Intraoperative aortic valve (AV) damage [30 days]

    Aortic valve damage caused by the cusp sizer (cusp tear or perforation), rate of conversion from AV repair to AV replacement due to the use of the cusp sizer

  2. Hospital mortality [30 days]

    Patient Survival status at 30 days after surgery

  3. Major adverse cardiac and cerebrovascular events (MACCE) [one year]

    Mortality, stroke or transient ischemic attack, major bleeding, cardiac reintervention

  4. Aortic valve function [One year]

    Aortic valve regurgitation and transvalvular gradient by transthoracic echocardiography

Secondary Outcome Measures

  1. Pre-repair free margin length [Intraoperative]

    Length of the 3 leaflets free margin before aortic valve repair

  2. Post-repair free margin length [Intraoperative]

    Length of the 3 leaflets free margin after aortic valve repair

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients with Tricuspid Aortic Valve (TAV) operated electively for aortic valve regurgitation and or ascending aorta dilatation.
Exclusion Criteria:
  • Acute aortic dissection;

  • Diffuse aortic valve calcification;

  • AV endocarditis;

  • Bicuspid, unicuspid or quadricuspid aortic valves;

  • Patients under the age of 18 years;

  • Patients above the age of 80 years.

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Cliniques universitaires Saint-Luc- Université Catholique de Louvain

Investigators

  • Principal Investigator: Laurent de kerchove, Cliniques universitaires Saint-Luc- Université Catholique de Louvain

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
ClinicalTrials.gov Identifier:
NCT04797572
Other Study ID Numbers:
  • CALIBRATE TRIAL01
  • 2020-14DEC/619
First Posted:
Mar 15, 2021
Last Update Posted:
Mar 15, 2021
Last Verified:
Mar 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 15, 2021